Two Sigma Advisers
FLGT icon

Two Sigma Advisers’s Fulgent Genetics FLGT Stock Holding History

Two Sigma Advisers’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-193,500
Closed -$5.08M – 781
2025
Q4 		$5.08M Buy
193,500
+107,200
+124% +$2.78M 0.01% 804
2025
Q3 		$1.95M Buy
86,300
+24,500
+40% +$505K ﹤0.01% 1147
2025
Q2 		$1.23M Sell
61,800
-4,000
-6% -$78K ﹤0.01% 1348
2025
Q1 		$1.11M Sell
65,800
-17,200
-21% -$293K ﹤0.01% 1427
2024
Q4 		$1.53M Buy
83,000
+19,000
+30% +$371K ﹤0.01% 1250
2024
Q3 		$1.39M Buy
64,000
+39,500
+161% +$883K ﹤0.01% 1260
2024
Q2 		$481K Buy
+24,500
New +$511K ﹤0.01% 1898
2020
Q3 		– Sell
-11,200
Closed -$179K – 2467
2020
Q2 		$179K Sell
11,200
-4,100
-27% -$62.8K ﹤0.01% 2275
2020
Q1 		$165K Sell
15,300
-17,600
-53% -$245K ﹤0.01% 2217
2019
Q4 		$424K Buy
+32,900
New +$391K ﹤0.01% 1940

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Advisers's FLGT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 193,500 shares — an estimated $5.08M sold.

Two Sigma Advisers first reported a position in FLGT in Q4 2019 and held it in 10 quarters. The position peaked at $5.08M in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 193,500 Fulgent Genetics shares in Q1 2026, an estimated $5.08M.
  • Two Sigma Advisers first reported a position in Fulgent Genetics in Q4 2019 and held it in 10 quarters.
  • Two Sigma Advisers's Fulgent Genetics position peaked at $5.08M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.